A newly formed pharmaceutical company was creating a novel cardiometabolic drug, a new small molecule, that was in Phase 2a testing in the United States and Canada. Renejix provided integrated development, manufacturing, and clinical supply solutions. Clinix Total Supply is an integrated method that integrates early-phase development with clinical supply production and distribution to shorten the road to the clinic. This complete method was implemented to enhance supply chain management and accelerate development schedules. This case study focuses on the problems encountered, the techniques used, and the results obtained via the deployment of an integrated development, manufacturing, and clinical supply solution.
Similar Posts
6 Different Phases of Drug Development and Manufacturing
The pharmaceutical industry is a cornerstone of modern healthcare, providing innovative solutions to an array of medical challenges. The journey from a…
How to Overcome Challenges for Accelerated Drug Development
“New drugs receiving expedited approval have shorter timelines, which can create unique challenges for development and manufacturing. Joe Dukich, director of operations…
The Role of CDMOs in Accelerating Orphan Drug Development
Orphan drugs are vital for treating rare diseases that affect a small percentage of the population. However, developing these drugs poses significant…
Small Molecule Analytical Services
This document provides both a high-level overview of Renejix’s stand-alone small molecule analytical services, and a detailed list of services organized by…